Organs-on-a-chip: a fast track for engineered human tissues in drug development

K Ronaldson-Bouchard, G Vunjak-Novakovic - Cell stem cell, 2018 - cell.com
Organs-on-a-chip (OOCs) are miniature tissues and organs grown in vitro that enable
modeling of human physiology and disease. The technology has emerged from converging …

Organ-on-a-chip devices advance to market

B Zhang, M Radisic - Lab on a Chip, 2017 - pubs.rsc.org
To curb the high cost of drug development, there is an urgent need to develop more
predictive tissue models using human cells to determine drug efficacy and safety in advance …

Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility

J Barc, R Tadros, C Glinge, DY Chiang, M Jouni… - Nature …, 2022 - nature.com
Brugada syndrome (BrS) is a cardiac arrhythmia disorder associated with sudden death in
young adults. With the exception of SCN5A, encoding the cardiac sodium channel NaV1. 5 …

Lymphoangiocrine signals promote cardiac growth and repair

X Liu, E De la Cruz, X Gu, L Balint, M Oxendine-Burns… - Nature, 2020 - nature.com
Recent studies have suggested that lymphatics help to restore heart function after cardiac
injury,,,,–. Here we report that lymphatics promote cardiac growth, repair and …

Integrating organoids and organ-on-a-chip devices

Y Zhao, S Landau, S Okhovatian, C Liu… - Nature Reviews …, 2024 - nature.com
Organoids and organs-on-chips are two rapidly emerging 3D cell culture techniques that
aim to bridge the gap between in vitro 2D cultures and animal models to enable clinically …

[HTML][HTML] Cardiovascular disease models: a game changing paradigm in drug discovery and screening

H Savoji, MH Mohammadi, N Rafatian, MK Toroghi… - Biomaterials, 2019 - Elsevier
Cardiovascular disease is the leading cause of death worldwide. Although investment in
drug discovery and development has been sky-rocketing, the number of approved drugs has …

SIRT2 counteracts primate cardiac aging via deacetylation of STAT3 that silences CDKN2B

Y Ye, K Yang, H Liu, Y Yu, M Song, D Huang, J Lei… - Nature Aging, 2023 - nature.com
Aging is a major risk factor contributing to pathophysiological changes in the heart, yet its
intrinsic mechanisms have been largely unexplored in primates. In this study, we …

Translation of human-induced pluripotent stem cells: from clinical trial in a dish to precision medicine

N Sayed, C Liu, JC Wu - Journal of the American College of Cardiology, 2016 - jacc.org
The prospect of changing the plasticity of terminally differentiated cells toward pluripotency
has completely altered the outlook for biomedical research. Human-induced pluripotent …

[HTML][HTML] PPARdelta activation induces metabolic and contractile maturation of human pluripotent stem cell-derived cardiomyocytes

NM Wickramasinghe, D Sachs, B Shewale… - Cell Stem Cell, 2022 - cell.com
Pluripotent stem-cell-derived cardiomyocytes (PSC-CMs) provide an unprecedented
opportunity to study human heart development and disease, but they are functionally and …

Identification of drug transporter genomic variants and inhibitors that protect against doxorubicin-induced cardiotoxicity

T Magdy, M Jouni, HH Kuo, CJ Weddle, D Lyra-Leite… - Circulation, 2022 - Am Heart Assoc
Background: Multiple pharmacogenomic studies have identified the synonymous genomic
variant rs7853758 (G> A, L461L) and the intronic variant rs885004 in SLC28A3 (solute …